chrisvoncsefalvay/vaers-outcomes huggingface dataset:
His arm was still really sore; Chills; Fever of 99.1; Injection site swelling; Injection site pain; Sweating; His arm to be swollen; Muscle pain; This is a spontaneous report from a contactable consumer (patient's wife). A 51-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right arm on 25Mar2021 13:15 (at the age of 51-year-old) (Lot number and expiration date was not reported) as dose 1, single for COVID-19 immunization. The vaccine was administered in hospital. The patient medical history included slightly elevated prostate. The concomitant medications included (ibuprofen) ADVIL for unknown indication. The patient experienced muscle pain, arm swollen, injection site swelling and injection site pain on 25Mar2021. On 26Mar2021, patient woke up at 1:30 in a sweat. The patient did not check his temperature at the time, but thought his fever was breaking. The patient woke up in the morning with chills, and his arm was still really sore. On same day, the patient was had fever and temperature during the lunch was 99. The patient received ibuprofen 200 mg capsules (Kirkland brand) as treatment for the events. The outcome of event muscle pain and arm sore was unknown. The outcome of event arm swollen and pyrexia was recovering and outcome of other events was recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
No adverse reaction.  Patient given one booster shot in 11/30/21 and a fourth on 2/25/22.  No side effects no  physical reaction.
2 days fever, H/A, (L) arm pain. Persistant pain (L) arm.
I experienced chest pain or discomfort intermittently mid-day and afternoon. It subsided after this point. The night of 1/13/21, I fell asleep but awoke multiple times cold. I experienced the chills through about midnight. The next morning, 1/14/21, I woke up with a headache at about 5:30am. I took a dose of Aleve and the symptoms had subsided by about 6:30am
After the first vaccine, my right shoulder/neck area was swollen and painful into my jaw, cheek, temple and head. The swelling would not go down and I had to get a cortisone injection in it. After the second vaccine, I woke up 2 days later with sores/lesions on my face (left cheek, between my eyebrows and on my chin) with swelling present. I went to the emergency room, had a CT scan and blood work done, and was put on Doxycycline tablets and Mupirocin ointment.
This spontaneous report as received from a registered nurse refers to a female patient of unknown age who on 28-JUN-2011 was vaccinated with a first dose of GARDASIL (dose, lot #, expiration date and route were not reported) and on 06-JAN-2012 received second dose of GARDASIL (dose, lot #, expiration date and route were not reported). No adverse effects were reported. It was unknown if the patient sought medical attention. Additional information has been requested.
This spontaneous report as received from a physician via a company representative refers to a 60 year old female patient. The patient's current conditions included rheumatoid arthritis and the patient was on methotrexate, stopped 3 months before vaccination. On an unspecified date, the patient was vaccinated with a dose of ZOSTAVAX vial (dose, route, lot number and expiration date were not reported). On an unspecified date, the patient got chickenpox on her face, the patient was seen in the office on December-2013, with vesicles on the face, vesicles were cultured and found to be varicella. At the time of the report the patient was recovered from varicella, the patient recovered on an unknown date. The patient went to the physician's office for medical attention and varicella was treated with Famciclovir at an unspecified date and the patient started on an unspecified biological medication for rheumatoid arthritis approximately in February 2014, 2 months after the patient was seen at the physician's office. Additional information has been requested.
Pt went to hospital due to vaccine given too high and was in lymphatic system.  thought she had a stroke.  she was in hospital for the last week
:  I received my first Moderna vaccination yesterday at the clinic. My injection was located about tree inches below my deltoid muscle. My family doctor's reaction was, " Oh no". According to the literature, the efficacy of a misplaced injection could be compromised. She suggested that I contact you (vaccine clinic) for directions. Please advise.
4 hrs p/vax devel t101 that inc t104 later that noc; cried for approx 3 hrs intermittently consoled for brief periods; refused bottle; next AM t101;
patient is 3 weeks past due date for the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient is 3 weeks past due date for the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient is 3 weeks past due date for the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient is 3 weeks past due date for the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
16 year old received adult dose; 16 year old received adult dose; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 16-year-old male patient who received HAV (Havrix adult) (batch number 2ba99, expiry date 16th December 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 16th September 2022, the patient received the 1st dose of Havrix adult and Havrix Pre-Filled Syringe Device. On 16th September 2022, unknown after receiving Havrix adult and Havrix Pre-Filled Syringe Device, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 16-Sept-2022 Reporter's comment: The reporter consented to follow-up via email. Additional supportive information: The patient received an adult dose of Havrix, which led to overdose and adult product administered to child.
Fever up to 101.1F; chills; full body aches; headaches; stiffness/pain in neck/back; exhaustion; inappropriate schedule of vaccine administered; This is a spontaneous report received from a non-contactable physician (patient).  A 30-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/lot number: EL3247; Expiration date not reported) via an unspecified route of administration, in right arm on 01Feb2021 (at the age of 30 years) as a single dose for COVID-19 immunization. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Batch/lot number: EL3249 and Expiration date not reported) via an unspecified route of administration, in right arm on 13Jan2021 as a single dose for COVID-19 immunization. The concomitant medications included Tylenol (PRN), Empresse OCP, Vitamin D and fish oil. The Facility where the most recent COVID-19 vaccine was administered was reported as Hospital. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient was allergic to Tylenol cold and flu liquid. On 02Feb2021, the patient had experienced Fever up to 101.1F, chills, full body aches, headaches, stiffness/pain in neck/back, exhaustion. The laboratory tests and procedures include Body temperature with results 101.1 F. The treatment received included Tylenol. The clinical outcome for the events Fever up to 101.1F, chills, full body aches, headaches, stiffness/pain in neck/back, exhaustion was reported as recovering. The outcome for inappropriate schedule of vaccine administered was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Entered post-monitoring area at 1750, notified RN of prior itching and hives post first dose COVID-19 vaccination. Reported that she had taken Benadryl 50mg PO after first vaccination. Pt reported today 1/7/20, she took medication prior to COVID-19 vaccination: Pepcid 40mg PO at 1626. Benadryl 25mg PO at 1626.  1810: pt c/o scalp itching, visible redness to itchy area on scalp. BP 158/84 (101), HR 82, regular rhythm, SpO2 97%, RR 18, Temp=97.5F  1812: 25mg Diphenhydramine HCL oral solution given PO for itching to scalp.  1818: BP 159/93 (108), HR 78, regular rhythm, SpO2 98%, RR 17, Temp =98 F  1822: Splotchy redness noted to pt's L lower arm, no itching. Redness noted to L upper chest with pt c/o itching to L upper chest area, R neck, nose and R toes itching. Pt denies difficulty breathing, swallowing. SpO2=98%  1830: BP 172/84 (105), HR 82, regular rhythm, SpO2 100%, RR 16, Temp=97.5 F Pt denies any new areas of itching, scalp, R toes, R neck and R chest area still itchy. No c/o difficulty swallowing or breathing. No throat clearing.  1837: pt notes improvement in scalp and nose itching. Redness to L arm and chest improved.  1845: BP 165/80 (102), HR 85, regular rhythm, RR 16, SpO2=99%, Temp =98.2 F Pt c/o itching again to R side of scalp with redness noted to scalp.  1850: 25mg Diphenhydramine HCL oral solution given PO for itching and redness to scalp.  1900: BP 153/87 (104), HR 85, regular rhythm, RR 12, SpO2=98%, Temp=97.6 F Pt reports mild scalp itching with some improvement since second dose of diphenhydramine. No other itching or redness noted.  1915: BP 171/86 (107), HR=80, regular rhythm, RR 12, SpO2=99%, Temp=97.4 F pt reports mild itching to L scalp and L chest, no significant redness noted.  1930: Pt denies worsening symptoms, no additional itching or redness. Gave pt discharge instructions to not exceed 100mg of Diphenhydramine in a 4 hour period. Recorded times and amounts of diphenhydramine given during post vaccine monitoring period. Pt denies feeling drowsy and is comfortable driving home. Directed patient to call emergency services from home with any worsening of rash or trouble breathing, feeling faint, or any other concerning symptoms. Pt's husband will be at home with pt, aware of additional monitoring needed post vaccine.
has a bad rash on his right wrist underneath his palm that looks like eczema; it feels like it wants to come out on his left wrist; It started after the 1st dose, looked like it was going away, then after the 2nd dose it got severely red & worse; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (has a bad rash on his right wrist underneath his palm that looks like eczema), FEELING ABNORMAL (it feels like it wants to come out on his left wrist) and RASH ERYTHEMATOUS (It started after the 1st dose, looked like it was going away, then after the 2nd dose it got severely red & worse) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022J21A and 013H21B) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2022, the patient experienced ECZEMA (has a bad rash on his right wrist underneath his palm that looks like eczema), FEELING ABNORMAL (it feels like it wants to come out on his left wrist) and RASH ERYTHEMATOUS (It started after the 1st dose, looked like it was going away, then after the 2nd dose it got severely red & worse). At the time of the report, ECZEMA (has a bad rash on his right wrist underneath his palm that looks like eczema), FEELING ABNORMAL (it feels like it wants to come out on his left wrist) and RASH ERYTHEMATOUS (It started after the 1st dose, looked like it was going away, then after the 2nd dose it got severely red & worse) outcome was unknown.            No Concomitant medications were reported No Treatment medications were reported   This case was linked to MOD-2022-466161 (Patient Link).
Information has been received from a physician and the office manager concerning a 7 month old female patient who on 22-JAN-2009, was vaccinated with PNEUMOVAX (lot # 661934/1441X) instead of PREVNAR by mistake due to an office error.  It is unknown if the patient sought medical attention.  Follow up information was received from the physician which reported that the patient was vaccinated IM with PNEUMOVAX (lot # 661934/1441X).  There was no illness at the time of vaccination.  No reactions or adverse events were reported.  The patient did not seek medical attention.  This is one of several reports from the same source.  Additional information is not expected.
Information has been received from a physician concerning someone that one of his patients knew who on an unspecified date was vaccinated with a dose of GARDASIL (route and lot # not reported). Subsequently the patient had a experienced seizure post vaccination. The physician stated that the patient was not his patient and the adverse experience was hear say. Attempts are being made to verify the existence of an identifiable patient. Upon internal review, seizure was determined to be an other important medical event. Additional information has been requested.
Moderna vaccine vials (Lot#002C21A, Expiration date 10/14/21) had been removed from the freezer and sent from a larger healthcare facility within our organization. Pharmacy stored the vials in the medication fridge, with a fridge expiration of 6/24/21. The fridge expiration date was written on the bag that the vial of the vaccine was in, but not on the vial itself. Nursing  drew up a vial of vaccines on 6/30/21 without looking at the fridge expiration date on the bag and administered to 8 patients. Pharmacy discovered expired vials on 7/9/21. No adverse reactions noted. Notified Moderna on 7/12/21 and no further actions recommended, instructed not to give another dose.
Irregular monthly periods for the lasted six months. Periods every other week and one that lasted for three weeks. With very painful cramping, breast tenderness, swollen and tenderness in the pelvic area.
On Sunday, June 22 child became ill. On Monday June 23 and Tuesday June 24 pt had a fever of 100.5. Pt started with rash on Thursday June 26. Pt was seen by private physician on June 27 and diagnosed with adverse event to MMR vaccine.
Oblong rash that ends at top of bicep below the injection site, also swollen, pain if touched, and skin hot to the touch. 5/7 still same oblong rash, still hot, almost no pain, less swollen.  Ice and Aleve. Currently, as long as nobody touches it my arm feels normal (unless I brush it against something hard).
ringing in my ears; This is a spontaneous report from a contactable consumer or other non hcp.   A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had received the 1st dose received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization and had no issue. The patient experienced "ringing in my ears" on an unspecified date. It was reported that the patient regretted taking the Pfizer shot. The first shot went fine. After the second shot, the patient have had ringing in ears. The patient went to family doctor and was told there isn't anything that can be done about it. The patient knew others that have the same thing going on. The patient never had any issues prior to taking the shot. The patient reported that is why they sign a release form. The patient reported would never again take any booster shots in the future. Outcome of the event was unknown.  Information about lot/batch no has been requested.
O41.03X1 - Oligohydramnios antepartum, third trimester, fetus 1
This spontaneous report as received from a healthcare worker, referring to patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 13-MAR-2017, the patient was vaccinated with improperly stored dose VARIVAX which had Lot number M033905 with expiry date on 20-JUL-2018 (strength and route were not reported) for prophylaxis, however no adverse effects were reported.  It was reported that the vaccine was exposed to a temperature as follows: >14 farenheit grade but < 46 farenheit grade for 40 minutes; >14 farenheit grade but < 46 farenheit grade for 40 minutes; >14 farenheit grade but < 46 farenheit grade for 50 minutes and had a previous excursion recorded by a data logger of >14farenheit grade  but < 46 farenheit grade  for "5.3 hours" and >14 farenheit grade but < 46 farenheit grade for 50 minutes. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1703USA008241: US-009507513-1703USA008242: US-009507513-1703USA008243:
After each of the two shots, I experienced severe abdominal cramping and aggressively vacating diarrhea, unlike anything I'm used to in my day-to-day life. First I felt a few sharp pangs in my gut, and thought nothing of it. I then needed to spend an extended amount of time in the bathroom, surprising my poor partner who was mid-shower.   I began to feel nausea and worried I was going to throw up, the first time, and at one moment in the steamed bathroom I noticed that my vision started to cloud and fade, as if I was about to pass out, which isn't something I've experienced either.  It passed rather quickly, and partner believed it was food poisoning so I didn't report it. Then it happened again.  Each time it occurred I *think* about 30 hours after getting the vaccine, so when I already thought I was turning a corner on the faux-flu-like   symptoms I was feeling  from the vaccine.    It was still worth it, to get my shots, but I thought I should contribute my tally mark to "crippling, sudden, and cruel diarrhea" to the list of side effects since I haven't heard others really talk about it.
pt recvd vax 22DEC95 about 5PM in MD office;OM dx early morning (about 2AM) 23DEC95 pt had febrile convuls;adm to hosp given valium IV;no further seizuring;
Fever, chills, fatigue for 12 hours, left arm tenderness for 2 days.
Approx 12 hours after receiving second dose of covid vaccine, I experienced what I can only describe as moderate-strong flu symptoms. I had previously had a mild reaction to the first vaccine (fatigue, mild headache) so I was shocked at how incapacitated I was after the second vaccine. 9:00pm (Wednesday)  (12 hours after vaccine) - after feeling ok all day, starting to feel sick, chills yet feeling hot (fever at 101.4), muscles and joints aching and headache; 9:00pm-4:00am - very intense flu like symptoms, muscle and joint aching extreme, burning and deep pain on arm at injection site, chills not going away.  I eventually fall asleep. 7:00am (Thursday) - call my mother to come pick me up because I am still feeling poorly.  Fever is gone but I have a major headache and body aches are persistent. I take Tylenol and some of the body aches are better. I continue to feel like this throughout the entire day off and on. 7:00am (Friday) - finally feeling better but I have a lingering sense of extreme nausea that won't go away. My stomach itself is "fine" but the nausea is persistent. I take dramamine and feel somewhat better. 7:00am (Saturday) - still feeling fatigued but almost feeling like myself again. Nausea is still present but has greatly diminished. 7:00am (Sunday) - finally feeling mostly "ok" again. No noticeable major effects that are interfering with my ability to go about my day.
This case was reported by a healthcare professional (nurse) and described the occurrence of jaundice in a 29-year-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent vaccination included ENGERIX B; GlaxoSmithKline; unknown; unknown given on 11 April 2013. On an unspecified date, the subject possibly received 3rd dose of ENGERIX B (unknown details) and possibly experienced drug dose administration interval too long. On 22 May 2013 the subject received 2nd dose of ENGERIX B (20 mcg, unknown route, left arm) and experienced drug dose administration interval too long. In June 2013, 3 weeks after vaccination with ENGERIX B, the subject experienced jaundice. At the time of reporting the event was resolved. The nurse did not report when the jaundice resolved. It was unknown if the immunization series was delayed or discontinued. It was unknown if the subject sought medical attention for the event. The healthcare professional considered the event was unrelated to vaccination with ENGERIX B. The nurse and the subject's healthcare provider "do not believe the jaundice is related to ENGERIX-B."
Patient received vaccine at 5 PM, went home and started feeling ill at 9 PM. Drove himself to hospital experiencing shortness of breath. Was given "breathing treatment" at the hospital and felt better after. Was discharged at 5 AM with diagnosis of acute bronchial spasm.